Erich Mynock

Erich Mynock has a diverse work experience spanning over several years in the clinical and pharmaceutical industries. Erich currently holds the position of Clinical Project Coordinator at Surrozen since 2022. Prior to that, Erich worked as a Procurement Specialist at the Bay Area Air Quality Management District from December 2021 to June 2022.

From 2019 to 2021, Erich served as a Distribution Site Manager at DirectMail, AG. Before that, they were a Clinical Operations Specialist at BlackThorn Therapeutics from April 2016 to July 2018. Erich also worked as a Clinical Trial Associate at Balance Therapeutics from March 2015 to March 2016.

In their earlier career, Erich held various roles at different companies. Erich worked as a Grants and Publications Coordinator at Actelion from March 2014 to March 2015. Erich also served as a Global Studies Associate at Genentech from March 2013 to March 2014 and as a Sr. Clinical Trial Assistant at Hyperion Therapeutics from March 2013 to February 2014.

Erich's experience includes roles as a Regulatory Affairs Coordinator at Hyperion Therapeutics from May 2010 to February 2012, and as a Clinical Trials Assistant at Proteolix from February 2008 to January 2010. Throughout their career, Erich has gained comprehensive knowledge and skills in clinical project coordination, procurement, distribution management, clinical operations, clinical trials, regulatory affairs, and grant and publication coordination.

Erich Mynock attended San Francisco State University from an unspecified start year until 2000. No specific degree or field of study was mentioned.